Neoantigen polypeptide vaccine

BIOLOGICAL2 trials

Sponsors

Second Affiliated Hospital of Guangzhou Medical University, Second Affiliated Hospital of Wenzhou Medical University

Conditions

Epithelial Ovarian CancerSolid Tumor, Adult

Phase 1

Anti-cancer Neoantigen Polypeptide Vaccine to Treat Solid Tumors

RecruitingNCT06195293

Second Affiliated Hospital of Guangzhou Medical UniversitySolid Tumor, Adult

Start: 2024-06-04End: 2037-12-30Target: 30Updated: 2024-06-26

Phase 2

Application of MRD Combined With Personalized Vaccine in the Treatment of Postoperative Recurrence Prevention of EOC

RecruitingNCT06341907

Second Affiliated Hospital of Wenzhou Medical UniversityEpithelial Ovarian Cancer

Start: 2024-01-01End: 2026-12-31Target: 10Updated: 2024-04-02